Antitumor activity of nivolumab on hemodialysis after renal allograft rejection
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Antitumor activity of nivolumab on hemodialysis after renal allograft rejection have?
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection has 81 citations in the OpenAlex counts ScholarIQ stores.
When was Antitumor activity of nivolumab on hemodialysis after renal allograft rejection published?
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection has 2016 year in the ScholarIQ index.
What is the open-access status of Antitumor activity of nivolumab on hemodialysis after renal allograft rejection?
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection has gold oa status in the ScholarIQ index.
What is the DOI of Antitumor activity of nivolumab on hemodialysis after renal allograft rejection?
The DOI for Antitumor activity of nivolumab on hemodialysis after renal allograft rejection is on the source record.
What is the PMID of Antitumor activity of nivolumab on hemodialysis after renal allograft rejection?
The PMID for Antitumor activity of nivolumab on hemodialysis after renal allograft rejection is on the source record.
What is the OpenAlex record for Antitumor activity of nivolumab on hemodialysis after renal allograft rejection?
The OpenAlex for Antitumor activity of nivolumab on hemodialysis after renal allograft rejection is on the source record.